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This special issue is focused on the current approaches used
to identify and manage particular groups of glaucoma that
we define as challenging glaucomas, because of difficulties in
either diagnosis or therapy.
Malignant glaucoma is a good example of difficulties in
both diagnosis and management, and J. Foreman-Larkin et
al. provide a complete overview on the clinical management
of malignant glaucoma. Pseudoexfoliation is also typified by
very high pressures at times and rapid damage to the optic
nerve and P. Plateroti et al. focus their paper on pseudoex-
foliation syndrome and pseudoexfoliative glaucoma with a
review of the literature and updates on surgical management.
Raised pressure and inflammation can be very challenging
and D. Lewkowicz et al. cover the clinical outcome of
hypertensive uveitis. Infection after glaucoma surgery is one
of themost challenging situations andK.Ohtomo et al. report
their outcomes of late-onset bleb related endophthalmitis
treated with pars plana vitrectomy.
The aetiology of different variants of the glaucoma with
higher and lower ranges of pressure still poses a challenge
to us. D. Wro´bel-Dudzin´ska et al. describe the risk factors
in normal-tension glaucoma and high-tension glaucoma in
relation to polymorphisms of the endothelin-1 gene and the
endothelin-1 receptor typeA gene. Vascular changesmay play
a part in the pathogenesis of glaucoma, and E. C. Koch et
al. discuss blood pressure and heart rate variability in the
detection of vascular dysregulation in glaucoma.
Assessment of the cellular layers that get damaged may
provide further clues in the assessment and diagnosis, and
A. Perdicchi et al. present a research article on the evaluation
of agreement between HRT 3 and I-Vue OCT in glaucoma
and ocular hypertension patients comparing different tomo-
graphic approaches to evaluate retinal ganglion cells.
As the variety of topics presented in this special issue sug-
gests, there are still many difficulties related to the diagnosis
and therapies for glaucoma. This pathology, especially in its
most advanced stages, can have a real impact on the quality
of life and outlook of patients. L. Zuo et al. write about vision
health-related quality of life in Chinese glaucoma patients,
describing how glaucoma can influence the quality of life in
patients.
There are some particular forms of glaucoma, whichmore
than others, represent a challenge for the ophthalmologist.
For example, pigmentary glaucoma has many grey areas
that still need to be clarified, including its pathogenesis
and the involvement of retinal structures. As mentioned,
pseudoexfoliative glaucoma also presents many difficulties
for both clinical and therapeutic approaches.However, paedi-
atric forms of glaucoma represent one of the greatest clinical
challenges, due to the variation in diagnostic criteria as well
as in potential treatments and the response of individual
patients. This is especially the case with those forms of
glaucoma secondary to other congenital diseases of the
anterior segment of the eye, particularly if associated with
facial anomalies and other malformations of intraocular
structures. This group of disorders is particularly complex
for the ophthalmologist, with obstacles in the management
of these patients from diagnosis to treatment.
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However, daunting these challenges, the future looks
encouraging as recent advances in translational research are
reshaping modern ophthalmology including whole genome
analysis and understanding of epigenetic influences and
bioinformatics. This should allow the gradual identification
of the link between different clinical phenotypes and specific
mutation in genes regulating the normal formation and
maturation of the eye, which should ultimately give rise to
new therapeutic hypotheses and approaches.
Thanks to nanotechnologies, new methods of drug
administration and the controlled release of molecules used
to decrease intraocular pressure are being developed. Surgical
treatments are also moving forward with new minimally
invasive procedures and with other devices which show
promising results with fewer side effects.
Furthermore, recent diagnostic criteria define glaucoma
as a true neurodegenerative pathology, which affects not
only the eye but also the whole optic tract and possibly
involves the supportive cells of the central nervous system.
This is the reason why, not only will future research focus on
lowering IOP but also it will increasingly include therapies
with neuroenhancing and neuroprotective effects and, in the
most optimistic hypotheses, will lead to neuroregeneration.
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